idiopathic pulmonary fibrosis
Conditions
Interventions
Experimental group :It was used in ShenLong decoction granules, take orally three times a day, one bag each time, period of treatment for three months
Control group:It was used in ShenLong decoction granules placebo, take orally three times a day, one bag each time, period of treatment for three months
Sponsors
The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
50 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) The western medicine diagnostic criteria for idiopathic pulmonary fibrosis; (2) The TCM syndrome standard in accordance with qi and yin deficiency of lung and kidney, blood stasis of lung collaterals; (3) Patients with mild or moderate idiopathic pulmonary fibrosis; (4) The course of disease was less than 3 years; (5) Aged 50 to 80 years; (6) Two weeks did not take the drug which had a greater impact on the test; (7) Signed informed consent form.
Exclusion criteria
Exclusion criteria: (1) Severe primary diseases associated with heart, brain, lung, liver, kidney and hematopoietic systems; (2) Patients with pregnant or lactating and allergic to experimental drug; (3) Investigators with participating in other research in nearly two months; (4) Refusing or not signing informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease condition improvement rate;Effective rate of syndrome improvement;Quality of life of patients; | — |
Secondary
| Measure | Time frame |
|---|---|
| Lung CT;Lung function;Blood gas analysis;6 minute walk test;TCM syndrome score; | — |
Countries
China
Contacts
Public ContactXiaodong Lv
The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Outcome results
None listed